Quarterly Transactions Made in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). The information is specifically focused on institutions that hold shares of HALOZYME THERAPEUTICS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 4,784,561 | 3,705,135 | 8,489,696 | 5,622,976 | 2,485,363 | 8,108,339 | 381,357 | |
| Q1 2022 | 4,117,480 | 2,044,709 | 6,162,189 | 5,909,508 | 2,432,451 | 8,341,959 | -2,179,770 | |
| Q2 2022 | 8,784,659 | 4,684,122 | 13,468,781 | 10,462,804 | 748,071 | 11,210,875 | 2,257,906 | |
| Q3 2022 | 9,123,313 | 4,317,058 | 13,440,371 | 6,886,713 | 76,439 | 6,963,152 | 6,477,219 | |
| Q4 2022 | 5,278,515 | 4,586,725 | 9,865,240 | 8,489,191 | 0 | 8,489,191 | 1,376,049 | |
| Q1 2023 | 9,435,378 | 7,518,353 | 16,953,731 | 11,928,184 | 474 | 11,928,658 | 5,025,073 | |
| Q2 2023 | 9,569,099 | 2,318,747 | 11,887,846 | 7,477,030 | 1,237,330 | 8,714,360 | 3,173,486 | |
| Q3 2023 | 6,780,424 | 3,625,736 | 10,406,160 | 6,557,757 | 988,989 | 7,546,746 | 2,859,414 | |
| Q4 2023 | 8,532,602 | 4,468,483 | 13,001,085 | 9,193,881 | 0 | 9,193,881 | 3,807,204 | |
| Q1 2024 | 9,472,426 | 2,217,063 | 11,689,489 | 8,575,331 | 0 | 8,575,331 | 3,114,158 | |
| Q2 2024 | 6,301,226 | 3,248,232 | 9,549,458 | 7,730,017 | 0 | 7,730,017 | 1,819,441 | |
| Q3 2024 | 11,459,160 | 3,525,047 | 14,984,207 | 8,874,669 | 0 | 8,874,669 | 6,109,538 | |
| Q4 2024 | 22,755 | 5,110 | 27,865 | — | 27,865 | |||